800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

view all Clinical Trials

Overview

The purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IMP) administration.

Clinical Trial Information

Protocol

NCT05667142 IRB#: 30629

Phase

3

Condition(s)

Seizures

Investigator

Mercedes P. Jacobson, MD, Valeriya Poukas, MD and Avani A. Shah, MD

Coordinator

Kathleen Hatala, RN, BSN
215-707-4171

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, call 215-707-4171 or email [email protected].

Full Title

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures